Sultan R. Alharbi, MD, is an Associate Professor of Interventional Radiology at King Saud University, Riyadh, Saudi Arabia. He completed his Interventional Radiology fellowship training at Western University, Ontario, Canada, where he developed expertise in hepatobiliary interventions and embolization therapies. Dr. Alharbi’s clinical and research interests focus on transarterial chemoembolization (TACE), embolization techniques for liver tumors, and the integration of advanced imaging technologies in interventional oncology. He has authored several publications in the field, including his most recent work “Sultan’s Score: A Novel Predictive Score to Predict Complete Response Following Drug-Eluting Bead Chemoembolization” published in Cureus (2025). Dr. Alharbi is actively involved in academic teaching, the training of residents and fellows, and organizing specialized embolization training courses.
Sultan R. Alharbi, MD, is an Associate Professor of Interventional Radiology at King Saud University, Riyadh, Saudi Arabia. He completed his Interventional Radiology fellowship training at Western University, Ontario, Canada, where he developed expertise in hepatobiliary interventions and embolization therapies. Dr. Alharbi’s clinical and research interests focus on transarterial chemoembolization (TACE), embolization techniques for liver tumors, and the integration of advanced imaging technologies in interventional oncology. He has authored several publications in the field, including his most recent work “Sultan’s Score: A Novel Predictive Score to Predict Complete Response Following Drug-Eluting Bead Chemoembolization” published in Cureus (2025). Dr. Alharbi is actively involved in academic teaching, the training of residents and fellows, and organizing specialized embolization training courses.